Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus

Diabetologia

Volumn 42, Issue 4, 1999, Pages 406-412

  Makimattila S ^a   Nikkila K ^b   Yki Jarvinen H ^a,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Hospital Jorvi   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Energy balance; Glucose; Glucosuria; Leptin

Indexed keywords

INSULIN; INSULIN PITKA; LEPTIN; METFORMIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL METABOLIC RATE; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENERGY BALANCE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSURIA; HUMAN; INSULIN TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; AGED; BLOOD GLUCOSE; BODY COMPOSITION; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METFORMIN; MIDDLE AGED; WEIGHT GAIN;

EID: 0344609217     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051172     Document Type: Article

References (29)

1. Turner R, Cull C, Holman R (1996) United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124: 136-145
2. U.K. Prospective Diabetes Study Group (1995) U.K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes 44: 1249-1258
3. Yki-Järvinen H, Ryysy L, Kauppila M et al. (1997) Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82: 4037-4043
4. Franssila-Kallunki A, Groop L (1992) Factors associated with basal metabolic rate in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 962-966
5. Welle S, Nair KS, Lockwood D (1988) Effect of a sulfonylurea and insulin on energy expenditure in type II diabetes mellitus. J Clin Endocrinol Metab 66: 593-59
6. Shank ML, Del Prato S, DeFronzo RA (1995) Bedtime insulin/daytime glipizide: Effective therapy for sulfonylurea failures in NIDDM. Diabetes 44: 165-172
7. DeFronzo RA, Goodman AM (1995) Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 333: 541-549
8. Lee A, Morley JE (1998) Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res 6: 47-53
9. Stumvoll M, Nurjhan N, Perriello G, Dailey G, Gerich JE (1995) Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333: 550-554
10. Yki-Järvinen H, Kauppila M, Kujansuu E et al. (1992) Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 327: 1426-1433
11. Yki-Järvinen H, Puhakainen I, Saloranta C, Groop L, Taskinen M-R (1991) Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 260: E680-E689
12. Ferrannini E (1988) The theoretical bases of indirect calorimetry: a review. Metab Clin Exp 37: 287-301
13. Ohlson L-0, Larsson B, Svärdsudd K, Welin K et al. (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men in 1913. Diabetes 34: 1055-1058
14. Desbuquois B, Aurbach GD (1971) Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassay. J Clin Endocrinol Metab 33: 732-738
15. Armitage P (1971) Statistical methods in medical research. 1st edn. Blackwell Scientific Publications, Oxford, pp 279-284
16. Giugliano D, Quatraro A, Consoli G et al. (1993) Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol 44: 107-112
17. Ravussin E (1993) Energy metabolism in obesity. Studies in the Pima Indians. Diabetes Care 16: 232-238
18. Bogardus C, Taskinen M-R, Zawadzki J, Lillioja S, Mott D, Howard BV (1986) Increased resting metabolic rates in obese subjects with non-insulin-dependent diabetes mellitus and the effect of sulfonylurea therapy. Diabetes 35: 1-5
19. 13C nuclear magnetic resonance study. J Clin Invest 90: 1323-1327
20. Consoli A, Nurjhan N, Capani F, Gerich J (1989) Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38: 550-557
21. Efendic S, Wajngot A, Vranic M (1985) Increased activity of the glucose cycle in the liver: an early characteristic of type 2 diabetes. Proc Natl Acad Sci 82: 2965-2969
22. Umpleby AM, Scobie IN, Boroujerdi MA, Carson ER, Sönksen PH (1990) Diurnal variation in glucose and leucine metabolism in non-insulin-dependent diabetes. Diabetes Res Clin Pract 9: 89-96
23. Yki-Järvinen H, Helve E, Sane T, Nurjhan N, Taskinen M-R (1989) Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM. Am J Physiol 256: E732-E739
24. Himms-Hagan J (1976) Cellular thermogenesis. Ann Rev Physiol 37: 315-351
25. Caspary WF (1977) Biguanides and intestinal absorptive function. Acta Hep Gastroenterol 24: 473-480
26. Hermann LS, Melander A (1992) Biguanides: basic aspects and clinical uses. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P (eds) International Textbook of Diabetes Mellitus. John Wiley & Sons, Chichester, pp 773-795
27. Knowler WC, Pettitt DJ, Savage RJ, Bennett PH (1981) Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 113: 144-156
28. Taskinen M-R, Kuusi T, Helve E, Nikkilä E, Yki-Järvinen H (1988) Insulin therapy induces antiathrogenic changes in serum lipoproteins in non-insulin-dependent diabetes mellitus. Arteriosclerosis 8: 168-177
29. Yki-Järvinen H, Nikkilä E, Helve E, Taskinen M-R (1988) Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. Am J Med 84:185-192